Evaluating the perspective of patients with MS and related conditions on their DMT in relation to the COVID-19 pandemic in one MS centre in Australia

Objective: Patients with Multiple Sclerosis (MS) and on disease modifying therapies (DMTs) that can be immunosuppressive or immunomodulatory form a special group where risk of continuation of DMT needs to be taken into account with risk of contracting Covid-19. This concept can pose a degree of anxi...

Descripción completa

Detalles Bibliográficos
Autores principales: Seery, Nabil, Li, Vivien, Nguyen, Ai-Lan, Roos, Izanne, Buzzard, Katherine A, Atvars, Roberts, Taylor, Nicola, Tunnell, Kelsey, Carey, John, Dwyer, Chris, Taylor, Hasini Fernandoa Lisa, Baker, Josephine, Marriott, Mark P, Kilpatrick, Trevor J, Kalincik, Tomas, Monif, Mastura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493747/
https://www.ncbi.nlm.nih.gov/pubmed/32957057
http://dx.doi.org/10.1016/j.msard.2020.102516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493747/
https://www.ncbi.nlm.nih.gov/pubmed/32957057
http://dx.doi.org/10.1016/j.msard.2020.102516

Ejemplares similares